超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > Galenea
Galenea
Galenea Galenea

美國Galenea
Galenea是坐落于美國劍橋的一個新藥研發公司。 他主要研究治療中樞神經疾病(精神分裂癥)和呼吸系統疾病(siRNA)的公司。John幫助Galenea建立了他的管理團隊并獲得了500萬美元的科研投資。在John的努力下,Galenea與日本的Otsuka醫藥公司建立了良好的伙伴關系。

Galenea drug discovery is powered by comprehensive predictive tools built by the integration of unique screening technologies and sophisticated animal behavioral models. We utilize these in vitro and in vivo analytical tools together with multi-dimensional medicinal chemistry to design drugs that restore aberrant brain activity. Galenea believes their innovative approach will generate new mechanism-based therapeutics for central nervous system diseases.
Galenea is dedicated to enhancing lives through the discovery of innovative therapies for central nervous system diseases.

Galenea was founded on the ground-breaking work of Professors Susumu Tonegawa at the Massachusetts Institute of Technology and Maria Karayiorgou at Columbia University Medical Center (formerly at The Rockefeller University). Together, their laboratories obtained both behavioral and genetic evidence for the role of calcineurin in the pathogenesis of schizophrenia. This advance suggests that the calcineurin pathway is a potential untapped source of therapeutic targets for the development of mechanism-based treatments for the disease. With the goal of generating new therapeutics with a particular focus on the associated memory and cognition impairments characteristic of schizophrenia and related disorders, Galenea established a research and development partnership with Otsuka Pharmaceutical Co., Ltd. Otsuka is a global pharmaceutical company with proven success in the discovery and development of therapies for CNS diseases, including Abilify?, the world’s fastest growing antipsychotic agent.

Expanding our CNS focused pipeline, Galenea in-licensed a portfolio of 5-HT2C agonists for the treatment of obesity and other related disorders. The licensed indole-based agonists have demonstrated potent 5-HT2C receptor agonist activity, highly desirable selectivity against other closely-related serotonin receptor family members and significant reduction of food intake in animal models of obesity. Based on these characteristics, Galenea aims to produce a best-in-class molecule for the safe and effective treatment of obesity.

Galenea is located in a custom-designed facility at Technology Square in Cambridge, MA. Our scientists are engaged in cutting-edge translational research that focuses on building high-powered predictive tools to unravel the mechanisms of CNS diseases. Our goal is to be recognized as a leader in drug discovery by translating the insights gained from our tools into clinical candidates that yield truly innovative therapeutics. Further advancement of our drug candidates will be performed together with partners who have global pharmaceutical development and commercialization expertise.

?

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 91久久精品国产免费一区 | 亚洲黄色一区 | 特黄特黄aaaa级毛片免费看 | 国产成人综合久久精品尤物 | 亚洲欧美日韩电影 | 亚洲精品视频免费观看 | 美女洗澡一级毛片 | 国产精品一区二 | 一区二区三区成人 | 国产精品视频区 | 欧美日本一区二区 | 久久久高清国产999尤物 | 自拍偷拍欧美亚洲 | 久久久久无码国产精品一区 | 欧美天天干 | 国产最新在线视频 | 欧美亚洲另类视频 | 不卡一区二区在线观看 | 国产l精品国产亚洲区在线观看 | 在线观看国产一区 | 日本成本人观看免费fc2 | 国产aaaaa一级毛片无下载 | 高清国产在线 | 日日操狠狠干 | 日韩欧美一区二区三区免费看 | 亚洲视频网站在线观看 | 午夜影院欧美 | 欧美色图亚洲天堂 | 欧美午夜视频在线观看 | 激情综合亚洲欧美日韩 | 国产偷亚洲偷欧美偷精品 | 日本高清一区二区三区不卡免费 | 国产区亚洲区 | 欧美精品v日韩精品v国产精品 | 色国产精品一区在线观看 | 亚洲第七页 | 国产精品久久久久精 | 亚洲视频二 | 亚欧一区| 亚洲 中文 欧美 日韩 在线人 | 亚洲人一区|